E. Vuillemin

1.2k total citations
43 papers, 916 citations indexed

About

E. Vuillemin is a scholar working on Hepatology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, E. Vuillemin has authored 43 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 13 papers in Epidemiology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in E. Vuillemin's work include Liver Disease Diagnosis and Treatment (12 papers), Liver Disease and Transplantation (10 papers) and Immunotherapy and Immune Responses (4 papers). E. Vuillemin is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Liver Disease and Transplantation (10 papers) and Immunotherapy and Immune Responses (4 papers). E. Vuillemin collaborates with scholars based in France, Switzerland and United States. E. Vuillemin's co-authors include Paul Calès, Frédéric Oberti, Vincent Croquet, Marie Christine Rousselet, Daniel Chappard, Frédéric Moal, M. Namer, D. Serin, B. Audhuy and François Montestruc and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Hepatology.

In The Last Decade

E. Vuillemin

42 papers receiving 879 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
E. Vuillemin 410 258 246 159 127 43 916
Shanyu Qin 256 0.6× 277 1.1× 136 0.6× 226 1.4× 137 1.1× 76 1.1k
Takahiro Yoshikawa 226 0.6× 143 0.6× 131 0.5× 247 1.6× 164 1.3× 69 716
Cristian Perna 242 0.6× 314 1.2× 227 0.9× 134 0.8× 71 0.6× 47 1.0k
Marco Biolato 95 0.2× 455 1.8× 420 1.7× 150 0.9× 74 0.6× 50 965
Pablo León 119 0.3× 198 0.8× 48 0.2× 77 0.5× 78 0.6× 21 620
John G. Lunz 227 0.6× 289 1.1× 441 1.8× 1.1k 6.6× 93 0.7× 54 1.9k
Marie‐Claude Lescs 115 0.3× 131 0.5× 86 0.3× 75 0.5× 86 0.7× 12 623
Annie On‐On Chan 296 0.7× 863 3.3× 830 3.4× 346 2.2× 124 1.0× 30 1.9k
Hiroteru Kamimura 171 0.4× 245 0.9× 251 1.0× 142 0.9× 62 0.5× 86 867

Countries citing papers authored by E. Vuillemin

Since Specialization
Citations

This map shows the geographic impact of E. Vuillemin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Vuillemin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Vuillemin more than expected).

Fields of papers citing papers by E. Vuillemin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Vuillemin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Vuillemin. The network helps show where E. Vuillemin may publish in the future.

Co-authorship network of co-authors of E. Vuillemin

This figure shows the co-authorship network connecting the top 25 collaborators of E. Vuillemin. A scholar is included among the top collaborators of E. Vuillemin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Vuillemin. E. Vuillemin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pichon, Maxime, Thierry Barrioz, Chloé Plouzeau, et al.. (2020). Diagnostic Accuracy of a Noninvasive Test for Detection of Helicobacter pylori and Resistance to Clarithromycin in Stool by the Amplidiag H. pylori+ClariR Real-Time PCR Assay. Journal of Clinical Microbiology. 58(4). 68 indexed citations
2.
Bréhin, Anne‐Claire, Gaëlle Bougeard, Aude Lamy, et al.. (2017). Gestational choriocarcinoma associated with a germline TP53 mutation. Familial Cancer. 17(1). 113–117. 3 indexed citations
3.
4.
Veal, Nary, Frédéric Moal, Frédéric Oberti, E. Vuillemin, & Paul Calès. (2003). Hemodynamic Effects of Acute and Chronic Administration of Vapreotide in Rats with Cirrhosis. Digestive Diseases and Sciences. 48(1). 154–161. 4 indexed citations
5.
Fumoleau, P., R. Largillier, Véronique Dièras, et al.. (2003). Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer. European Journal of Cancer. 40(4). 536–542. 247 indexed citations
6.
Moal, Frédéric, Daniel Chappard, Jianhua Wang, et al.. (2002). Fractal dimension can distinguish models and pharmacologic changes in liver fibrosis in rats. Hepatology. 36(4). 840–849. 43 indexed citations
7.
Croquet, Vincent, Frédéric Moal, Nary Veal, et al.. (2002). Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension. Journal of Hepatology. 37(6). 773–780. 84 indexed citations
8.
Croquet, Vincent, E. Vuillemin, Catherine Ternisien, et al.. (2002). Prothrombin index is an indirect marker of severe liver fibrosis. European Journal of Gastroenterology & Hepatology. 14(10). 1133–1141. 60 indexed citations
9.
Veal, Nary, Frédéric Oberti, Frédéric Moal, et al.. (2000). Spleno-renal shunt blood flow is an accurate index of collateral circulation in different models of portal hypertension and after pharmacological changes in rats. Journal of Hepatology. 32(3). 434–440. 12 indexed citations
10.
Moal, Frédéric, et al.. (2000). Chronic hemodynamic effects of a new liver specific no donor (V-PYRRO/NO) in bile duct ligated (BDL) rats. Gastroenterology. 118(4). A978–A978. 2 indexed citations
11.
Rifflet, H, E. Vuillemin, Frédéric Oberti, et al.. (1998). [Suicidal impulses in patients with chronic viral hepatitis C during or after therapy with interferon alpha].. PubMed. 22(3). 353–7. 46 indexed citations
12.
Vuillemin, E., et al.. (1998). [Recurrent stomal hemorrhage treated by transjugular intrahepatic portosystemic anastomosis and embolization of stomal varices].. PubMed. 79(7). 690–2. 14 indexed citations
13.
Tourani, J.M., Virginie Lucas, Didier Mayeur, et al.. (1996). Subcutaneous recombinant interleukin-2 (rIL-2) in out-patients with metastatic renal cell carcinoma. Annals of Oncology. 7(5). 525–528. 28 indexed citations
14.
Rifflet, H, et al.. (1996). [Acute painful and febrile hepatic involvement related to ingestion of tianeptine].. PubMed. 20(6-7). 606–7. 5 indexed citations
15.
Vuillemin, E., et al.. (1996). [Turner syndrome and digestive telangiectasis: an additional value of estrogen-progestational treatment].. PubMed. 20(5). 510–1. 1 indexed citations
16.
Rixe, Olivier, E. Vuillemin, A. Benhammouda, et al.. (1995). A Phase II Study of Tamoxifen Combined with Cisplatin-Interleukin 2 and Alpha-Interferon in Metastatic Melanoma. American Journal of Clinical Oncology. 18(5). 421–424. 6 indexed citations
17.
Smith, M. J., Roger Mouawad, E. Vuillemin, et al.. (1994). Psychological side effects induced by interleukin‐2/α interferon treatment. Psycho-Oncology. 3(4). 289–298. 4 indexed citations
18.
Khayat, D., E Antoine, Olivier Rixe, et al.. (1993). Chemoimmunotherapy of metastatic malignant melanoma The Salpétrière Hospital (SOMPS) experiences. European Journal of Cancer. 29. S2–S5. 6 indexed citations
19.
Khayat, D., Christian Borel, J.M. Tourani, et al.. (1993). Sequential chemoimmunotherapy with cisplatin, interleukin-2, and interferon alfa-2a for metastatic melanoma.. Journal of Clinical Oncology. 11(11). 2173–2180. 116 indexed citations
20.
Khayat, D., E Antoine, Olivier Rixe, et al.. (1993). Interleukin2-alpha-interferon combined with cis-platyl therapy in metastatic malignant melanoma (MMM) patients: Results of two consecutive trials. European Journal of Cancer. 29. S179–S179. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shanyu Qin Breakdown of academic impact, for papers by Takahiro Yoshikawa Breakdown of academic impact, for papers by Cristian Perna Breakdown of academic impact, for papers by Marco Biolato Breakdown of academic impact, for papers by Pablo León Breakdown of academic impact, for papers by John G. Lunz Breakdown of academic impact, for papers by Marie‐Claude Lescs Breakdown of academic impact, for papers by Annie On‐On Chan Breakdown of academic impact, for papers by Hiroteru Kamimura
Rankless by CCL
2026